1. Home
  2. List
Reference Patent

Reference - List

  • 30 Hits
  • Search Condition : Filter (MeSH = Breast Neoplasms / drug therapy*)
Species Resource Title
Human and Animal Cells HSC-2(RCB1945) A landmark in drug discovery based on complex natural product synthesis.
Human and Animal Cells MCF7(RCB1904) Biofunctional supramolecular hydrogels fabricated from a short self-assembling peptide modified with bioactive sequences for the 3D culture of breast cancer MCF-7 cells.
Human and Animal Cells K562 The selective cytotoxicity of silver thiosulfate, a silver complex, on MCF-7 breast cancer cells through ROS-induced cell death.
Human and Animal Cells MCF7(RCB1904) , Hep G2 , 293(RCB1637) , NRK49F(RCB0112) , A549 , HeLa In Silico and In Cell Hybrid Selection of Nonrapalog Ligands to Allosterically Inhibit the Kinase Activity of mTORC1.
Human and Animal Cells MCF7(RCB1904) , HeLa(RCB0007) , WI-38(RCB0702) Systematic synthesis of low-molecular weight fucoidan derivatives and their effect on cancer cells.
Human and Animal Cells T98G(RCB1954) Synthesis, Photophysical Properties, and Biological Evaluation of trans-Bisthioglycosylated Tetrakis(fluorophenyl)chlorin for Photodynamic Therapy.
Human and Animal Cells MCF7(RCB1904) Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine.
Human and Animal Cells MC3T3-E1(RCB1126) Sprayable Adhesive Nanotherapeutics: Mussel-Protein-Based Nanoparticles for Highly Efficient Locoregional Cancer Therapy.
Human and Animal Cells KGN(RCB1154) Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models.
Human and Animal Cells MDA-MB-453(RCB1192) Luteolin attenuates doxorubicin-induced cytotoxicity to MCF-7 human breast cancer cells.
Human and Animal Cells OCUB-F(RCB0882) Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1.
Human and Animal Cells MCF7(RCB1904) , L929 GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Human and Animal Cells HL-60(RCB3683) Optimizing the dosing schedule of l-asparaginase improves its anti-tumor activity in breast tumor-bearing mice.
Human and Animal Cells SAS(RCB1974) Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models.
Human and Animal Cells MCF7(RCB1904) Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
Human and Animal Cells MCF7(RCB1904) The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
Human and Animal Cells MDA-MB-453(RCB1192) , MCF7(RCB1904) Transcriptional repression of HER2 by ANO1 Cl- channel inhibition in human breast cancer cells with resistance to trastuzumab.
Human and Animal Cells MDA-MB-453(RCB1192) , MCF7(RCB1904) Multifunctional Cu2-xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453.
Human and Animal Cells MCF7(RCB1904) Histamine H3 receptor antagonist OUP-186 attenuates the proliferation of cultured human breast cancer cell lines.
DNA material c-erbB2 promoter(533)-pGL2-basic (RDB02839) , c-erbB2 promoter(344)-pGL2-basic (RDB02840) , c-erbB2 promoter(251)-pGL2-basic (RDB02841) , c-erbB2 promoter(124)-pGL2-basic (RDB02842) , c-erbB2 promoter(251)-TK (RDB02843). A minimum c-erbB-2 promoter-mediated expression of herpes simplex virus thymidine kinase gene confers selective cytotoxicity of human breast cancer cells to ganciclovir.